1. Home
  2. SPRY vs AFYA Comparison

SPRY vs AFYA Comparison

Compare SPRY & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • AFYA
  • Stock Information
  • Founded
  • SPRY 2015
  • AFYA 1999
  • Country
  • SPRY United States
  • AFYA Brazil
  • Employees
  • SPRY N/A
  • AFYA N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • AFYA Other Consumer Services
  • Sector
  • SPRY Health Care
  • AFYA Real Estate
  • Exchange
  • SPRY Nasdaq
  • AFYA Nasdaq
  • Market Cap
  • SPRY 1.6B
  • AFYA 1.6B
  • IPO Year
  • SPRY N/A
  • AFYA 2019
  • Fundamental
  • Price
  • SPRY $17.69
  • AFYA $15.75
  • Analyst Decision
  • SPRY Strong Buy
  • AFYA Sell
  • Analyst Count
  • SPRY 4
  • AFYA 5
  • Target Price
  • SPRY $28.75
  • AFYA $17.60
  • AVG Volume (30 Days)
  • SPRY 1.6M
  • AFYA 108.7K
  • Earning Date
  • SPRY 08-05-2025
  • AFYA 08-15-2025
  • Dividend Yield
  • SPRY N/A
  • AFYA 1.51%
  • EPS Growth
  • SPRY N/A
  • AFYA 41.32
  • EPS
  • SPRY N/A
  • AFYA 1.31
  • Revenue
  • SPRY $97,122,000.00
  • AFYA $599,363,389.00
  • Revenue This Year
  • SPRY N/A
  • AFYA $15.52
  • Revenue Next Year
  • SPRY $170.64
  • AFYA $8.72
  • P/E Ratio
  • SPRY N/A
  • AFYA $11.95
  • Revenue Growth
  • SPRY 971120.00
  • AFYA 15.70
  • 52 Week Low
  • SPRY $8.91
  • AFYA $14.52
  • 52 Week High
  • SPRY $18.90
  • AFYA $19.90
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 60.97
  • AFYA 26.73
  • Support Level
  • SPRY $16.40
  • AFYA $17.33
  • Resistance Level
  • SPRY $18.05
  • AFYA $18.16
  • Average True Range (ATR)
  • SPRY 1.06
  • AFYA 0.43
  • MACD
  • SPRY 0.03
  • AFYA -0.18
  • Stochastic Oscillator
  • SPRY 62.54
  • AFYA 4.44

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Share on Social Networks: